Leandro J. Carreño

Dr. Leandro J. Carreño

Millennium Institute on Immunology and Immunotherapy, Programa de Inmunología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
ABAna Batista-Gonzalez
Ana Batista-Gonzalez
Roberto VidalRoberto Vidal
Roberto Vidal
ACAlfredo Criollo
Alfredo Criollo
Leandro J. CarreñoLeandro J. Carreño
Leandro J. Carreño
Macrophage activation is intimately linked to metabolic reprogramming. Inflammatory (M1) macrophages are able to sustain inflammatory responses and to kill pathogens, mostly by relying on aerobic glycolysis and fatty acid biosynthesis. Glycolysis is a fast way of producing ATP, and fatty acids serve as precursors for the synthesis of inflammatory mediators. On the opposite side, anti-inflammatory (M2) macrophages mediate the resolution of inflammation and tissue repair, switching their metabolism to fatty acid oxidation and oxidative phosphorylation. Over the years, this classical view has been challenged by recent discoveries pointing to a more complex metabolic network during macrophage activation. Lipid metabolism plays a critical role in the activation of both M1 and M2 macrophages. Recent evidence shows that fatty acid oxidation is also essential for inflammasome activation in M1 macrophages, and glycolysis is now known to fuel fatty acid oxidation in M2 macrophages. Ultimately, targeting lipid metabolism in macrophages can improve the outcome of metabolic diseases. Here, we review the main aspects of macrophage immunometabolism from the perspective of the metabolism of lipids. Building a reliable metabolic network during macrophage activation will bring us closer to targeting macrophages for improving human health.

17 March 2021 in Clinical Microbiology Reviews
Verified
Journal Article
Closed access
NGNicolas Galvez
Nicolas Galvez
KBKaren Bohmwald
Karen Bohmwald
GPGaspar Pacheco
Gaspar Pacheco
CACatalina Andrade
Catalina Andrade
Leandro J. CarreñoLeandro J. Carreño
Leandro J. Carreño
AKAlexis Kalergis
Alexis Kalergis
The immune system must work in an orchestrated way to achieve an optimal response upon detection of antigens. The cells comprising the immune response are traditionally divided into two major subsets, innate and adaptive, with particular characteristics for each type. Type I natural killer T (iNKT) cells are defined as innate-like T cells sharing features with both traditional adaptive and innate cells, such as the expression of an invariant T cell receptor (TCR) and several NK receptors. The invariant TCR in iNKT cells interacts with CD1d, a major histocompatibility complex class I (MHC-I)-like molecule.

1 March 2020 in Microbial Genomics
Verified
Journal Article
Open access
MAMónica Arteaga
Mónica Arteaga
JVJuliana Velasco
Juliana Velasco
SRShelly Rodriguez
Shelly Rodriguez
MVMaricel Vidal
Maricel Vidal
CACarolina Arellano
Carolina Arellano
David A. MonteroDavid A. Montero
David A. Montero
Vibrio cholerae is a human pathogen, which is transmitted by the consumption of contaminated food or water. V. cholerae strains belonging to the serogroups O1 and O139 can cause cholera outbreaks and epidemics, a severe life-threatening diarrheal disease. In contrast, serogroups other than O1 and O139, denominated as non-O1/non-O139, have been mainly associated with sporadic cases of moderate or mild diarrhea, bacteremia and wound infections. Here we investigated the virulence determinants and phylogenetic origin of a non-O1/non-O139 V. cholerae strain that caused a gastroenteritis outbreak in Santiago, Chile, 2018. We found that this outbreak strain lacks the classical virulence genes harboured by O1 and O139 strains, including the cholera toxin (CT) and the toxin-coregulated pilus (TCP). However, this strain carries genomic islands (GIs) encoding Type III and Type VI secretion systems (T3SS/T6SS) and antibiotic resistance genes. Moreover, we found these GIs are wide distributed among several lineages of non-O1/non-O139 strains. Our results suggest that the acquisition of these GIs may enhance the virulence of non-O1/non-O139 strains that lack the CT and TCP-encoding genes. Our results highlight the pathogenic potential of these V. cholerae strains.

20 December 2022 in mBio
Verified
Journal Article
Open access
Jorge A. SotoJorge A. Soto
Jorge A. Soto
FMFelipe Melo-González
Felipe Melo-González
CGCristián Gutierrez-Vera
Cristián Gutierrez-Vera
BSBárbara M. Schultz
Bárbara M. Schultz
RBRoslye V Berríos-Rojas
Roslye V Berríos-Rojas
AKAlexis Kalergis
Alexis Kalergis
This work evaluated the immune response induced by two doses of CoronaVac separated by 4 weeks in healthy children and adolescents in Chile. To date, few studies have described the effects of CoronaVac in the pediatric population.

7 December 2023 in Cancers
Verified
Journal Article
Open access
PDF file
ETEduardo Tognarelli Torres
Eduardo Tognarelli Torres
Cristián Gutiérrez-VeraCristián Gutiérrez-Vera
Cristián Gutiérrez-Vera
PPPablo Alberto Palacios Pedraza
Pablo Alberto Palacios Pedraza
IPIgnacio A. Pasten-Ferrada
Ignacio A. Pasten-Ferrada
FMFernanda Aguirre Muñoz
Fernanda Aguirre Muñoz
Leandro J. CarreñoLeandro J. Carreño
Leandro J. Carreño
Invariant natural killer T cells (iNKTs), a type of unconventional T cells, share features with NK cells and have an invariant T cell receptor (TCR), which recognizes lipid antigens loaded on CD1d molecules, a major histocompatibility complex class I (MHC-I)-like protein. This interaction produces the secretion of a wide array of cytokines by these cells, including interferon gamma (IFN-γ) and interleukin 4 (IL-4), allowing iNKTs to link innate with adaptive responses. Interestingly, molecules that bind CD1d have been identified that enable the modulation of these cells, highlighting their potential pro-inflammatory and immunosuppressive capacities, as required in different clinical settings. In this review, we summarize key features of iNKTs and current understandings of modulatory α-galactosylceramide (α-GalCer) variants, a model iNKT cell activator that can shift the outcome of adaptive immune responses. Furthermore, we discuss advances in the development of strategies that modulate these cells to target pathologies that are considerable healthcare burdens. Finally, we recapitulate findings supporting a role for iNKTs in infectious diseases and tumor immunotherapy.

27 April 2011 in Immunotherapy
Verified
Journal Article
Closed access
Leandro J. CarreñoLeandro J. Carreño
Leandro J. Carreño
Pablo Alberto GonzálezPablo Alberto González
Pablo Alberto González
SBSusan Bueno
Susan Bueno
CRClaudia A Riedel
Claudia A Riedel
AKAlexis Kalergis
Alexis Kalergis
The molecular interactions occurring at the interface between dendritic cells (DCs) and T cells play an important role in the immune surveillance against infectious agents, as well as in autoimmune pathogenesis. Therefore, regulation of this interaction arises as an important tool for the prevention and treatment of immune disorders and to improve the protection against pathogens without causing detrimental inflammation. Some of the molecular interactions defining the outcome of the DC-T cell interaction are: T-cell receptor (TCR) binding to the pMHC on the DC surface, which is responsible for the antigenic specificity; and the ratio of activating/inhibitory receptor pairs on the surface of DCs and T cells, which modulate DC immunogenicity and T-cell function, respectively. An alteration in the proper function of these molecules could lead to unbalanced DC-T-cell synapses that either cause a failure to control infections or exacerbated inflammation. Furthermore, some pathogens have developed molecular strategies to impair the function of the synapse to evade adaptive immunity. In this article, we will discuss recent work relative to the molecular mechanisms controlling DC-T-cell synapse and their implications on immunoregulation to control autoimmunity and potentiate pathogen immunity.